RT Journal Article
SR Electronic
T1 Development and validation of a modified Cambridge Multimorbidity Score for use with internationally recognized electronic health record clinical terms (SNOMED CT)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.02.22271765
DO 10.1101/2022.03.02.22271765
A1 Tsang, Ruby S. M.
A1 Joy, Mark
A1 Whitaker, Heather
A1 Sheppard, James P.
A1 Williams, John
A1 Sherlock, Julian
A1 Mayor, Nikhil
A1 Meza-Torres, Bernardo
A1 Button, Elizabeth
A1 Williams, Alice J.
A1 Kar, Debasish
A1 Delanerolle, Gayathri
A1 McManus, Richard
A1 Hobbs, F. D. Richard
A1 de Lusignan, Simon
YR 2022
UL http://medrxiv.org/content/early/2022/03/03/2022.03.02.22271765.abstract
AB Background People with multiple health conditions are more likely to have poorer health outcomes and greater care and service needs; a reliable measure of multimorbidity would inform management strategies and resource allocation. This study aims to develop and validate a modified version of the Cambridge Multimorbidity Score in an extended age range, using clinical terms which are routinely used in electronic health records across the world (SNOMED CT).Methods and Findings We curated new variables describing 37 health conditions and modelled the associations between these and 1-year mortality risk using the Cox proportional hazard model in a development dataset (n=300,000). We then developed two simplified models – a 20-condition model as per the original Cambridge Multimorbidity Score, and a variable reduction model using backward elimination with Akaike information criterion as the stopping criterion. The results were compared and validated for 1-year mortality in a synchronous validation dataset (n=150,000), and for 1-year and 5-year mortality in an asynchronous validation dataset (n=150,000).Our final variable reduction model retained 21 conditions, and the conditions mostly overlapped with those in the 20-condition model. The model performed similarly to the 37- and 20-condition models, showing high discrimination and good calibration following recalibration.Conclusions This modified version of the Cambridge Multimorbidity Score allows reliable estimation using clinical terms which can be applied internationally across multiple healthcare settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJPS is funded by the Wellcome Trust/Royal Society via a Sir Henry Dale Fellowship (ref: 211182/Z/18/Z). JPS also receives funding via an NIHR Oxford Biomedical Research Centre (BRC) Senior FellowshipAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of University of Oxford waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Oxford-RCGP RSC dataset can be accessed by researchers; approval is on a project-by-project basis (orchid.phc.ox.ac.uk/index.php/rcgp-rsc/). All patient-level data used was pseudonymised and in compliance with information governance policies. The analysis of the data was carried out in the secure servers at the University of Oxford. Patient-level data cannot be taken out of the secure network.